SCCA Antibodies

Santa Cruz Biotechnology features a diverse variety of SCCA Antibodies for research in the field of cancer biology. SCCA Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SCCA, or squamous cell carcinoma antigen, plays a significant role in the diagnosis and monitoring of squamous cell carcinoma, a common type of skin cancer. Elevated levels of SCCA in serum can indicate the presence of malignancy, making it an important biomarker in clinical settings. Understanding the function and regulation of SCCA provides insights into tumor progression and patient prognosis. Researchers worldwide utilize SCCA monoclonal antibodies to advance their understanding of cancer development and progression. Characterization of SCCA expression patterns helps identify potential therapeutic targets and develop new treatment strategies. SCCA monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to cancer research and therapeutic development.